Kestra Medical Technologies (KMTS) Receivables (2024 - 2026)

Kestra Medical Technologies (KMTS) has 3 years of Receivables data on file, last reported at $14.5 million in Q2 2026.

• On a quarterly basis, Receivables rose 79.95% year-over-year to $14.5 million in Q2 2026; TTM through Apr 2026 was $14.5 million, a 79.95% increase from a year earlier, with the FY2026 full-year figure at $14.5 million, up 79.95% from the prior year.
• Receivables for Q2 2026 stood at $14.5 million, up from $12.7 million in the prior quarter.
• Over the last five years, Receivables for KMTS reached as high as $14.5 million in Q2 2026 and fell as low as $2.0 million in Q2 2024.
• Historically, Receivables has averaged $9.3 million across 3 years, with a median of $9.2 million in 2025.
• Across the five-year window, Receivables surged 304.45% in 2025 and soared 60.29% in 2026, its largest moves.
• Year by year, Receivables stood at $2.0 million in 2024, then soared by 421.17% to $10.4 million in 2025, then surged by 39.65% to $14.5 million in 2026.
• Per Business Quant data, the three most recent Receivables figures were $14.5 million in Q2 2026, $12.7 million in Q1 2026, and $10.4 million in Q4 2025.